GROUP ONE TRADING, L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is and the CUSIP is 75955J952. A total of 7 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$540,900
-42.2%
180,300
-52.6%
0.00%
-33.3%
Q2 2023$936,030
+6271.9%
380,500
+5753.8%
0.00%
Q1 2023$14,690
-96.2%
6,500
-94.1%
0.00%
-100.0%
Q4 2022$387,041
-97.6%
110,900
-74.8%
0.00%
-96.9%
Q3 2022$16,267,000
+2841.6%
439,400
+1410.0%
0.03%
+3100.0%
Q2 2022$553,000
+750.8%
29,100
+1112.5%
0.00%
Q1 2022$65,000
+622.2%
2,400
+500.0%
0.00%
Q4 2021$9,000
-73.5%
400
-69.2%
0.00%
Q3 2021$34,000
+1033.3%
1,300
+1200.0%
0.00%
Q1 2020$3,000
-25.0%
1000.0%0.00%
Q4 2019$4,0001000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 93,000$3,443,0000.48%
Altium Capital Management LP 18,200$674,0000.25%
GROUP ONE TRADING, L.P. 439,400$16,267,0000.03%
SIMPLEX TRADING, LLC 134,000$4,960,0000.01%
JANE STREET GROUP, LLC 102,200$3,783,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 92,200$3,413,0000.00%
View complete list of RELMADA THERAPEUTICS INC shareholders